STOCK TITAN

[Form 4] Oscar Health, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Victoria Baltrus, identified as the issuer's Chief Accounting Officer, reported a transaction on 09/02/2025 involving Class A common stock of Oscar Health, Inc. (OSCR). The filing shows a Code F disposition on 09/02/2025 where 6,266 shares were withheld by the issuer to satisfy tax withholding at a reported price of $16.66 per share. After the transaction, Baltrus is reported to beneficially own 207,599 shares, which the filing states includes shares to be issued upon RSU vesting. The form was signed by an attorney-in-fact on 09/04/2025.

Victoria Baltrus, indicata come Chief Accounting Officer dell'emittente, ha riportato una transazione in data 02/09/2025 relativa alle azioni ordinarie di Classe A di Oscar Health, Inc. (OSCR). Il documento indica una cessione con Codice F il 02/09/2025 in cui 6.266 azioni sono state trattenute dall'emittente per soddisfare il prelievo fiscale, a un prezzo riportato di $16,66 per azione. Dopo l'operazione, a Baltrus sono attribuite in via beneficiaria 207.599 azioni, che il modulo precisa includono azioni da emettere al vesting delle RSU. Il modulo è stato firmato da un procuratore il 04/09/2025.

Victoria Baltrus, identificada como la Chief Accounting Officer de la emisora, reportó una transacción el 02/09/2025 que involucra acciones ordinarias Clase A de Oscar Health, Inc. (OSCR). El formulario muestra una disposición con Código F el 02/09/2025 en la que se retuvieron 6.266 acciones por parte de la emisora para cubrir la retención de impuestos, a un precio informado de $16.66 por acción. Tras la operación, a Baltrus se le atribuyen beneficiariamente 207.599 acciones, que el informe indica que incluyen acciones que se emitirán al consolidarse las RSU. El formulario fue firmado por un apoderado el 04/09/2025.

빅토리아 발트러스(Victoria Baltrus)는 발행회사의 최고 회계 책임자(Chief Accounting Officer)로서 2025-09-02에 Oscar Health, Inc.(OSCR) 보통주(Class A)에 대한 거래를 보고했습니다. 제출서류에는 코드 F에 따른 처분이 2025-09-02에 이루어졌으며, 6,266주가 세금 원천징수를 충당하기 위해 발행회사에 의해 원천징수되었고, 보고된 주당 가격은 $16.66였습니다. 거래 후 발트러스는 207,599주를 실질적 소유로 보고되었으며, 서류에는 이 숫자에 RSU 베스팅 시 발행될 주식이 포함된다고 기재되어 있습니다. 해당 양식은 2025-09-04에 대리인(공증인)에 의해 서명되었습니다.

Victoria Baltrus, identifiée comme Chief Accounting Officer de l'émetteur, a déclaré une transaction en date du 02/09/2025 portant sur des actions ordinaires de Classe A d'Oscar Health, Inc. (OSCR). Le dépôt indique une cession Code F le 02/09/2025 où 6 266 actions ont été retenues par l'émetteur pour couvrir la retenue fiscale, au prix communiqué de 16,66 $ par action. Après la transaction, Baltrus détient bénéficiairement 207 599 actions, le formulaire précisant que cela comprend des actions devant être émises lors du vesting des RSU. Le formulaire a été signé par un mandataire le 04/09/2025.

Victoria Baltrus, angegeben als Chief Accounting Officer des Emittenten, meldete am 02.09.2025 eine Transaktion mit Class-A-Stammaktien von Oscar Health, Inc. (OSCR). Die Einreichung weist eine Verfügung mit Code F zum 02.09.2025 aus, bei der 6.266 Aktien vom Emittenten einbehalten wurden, um die Steuerabzüge zu erfüllen, zu einem angegebenen Preis von $16,66 je Aktie. Nach der Transaktion besitzt Baltrus wirtschaftlich 207.599 Aktien, wobei das Formular angibt, dass dies Aktien umfasst, die bei Vesting von RSUs ausgegeben werden. Das Formular wurde am 04.09.2025 von einem Bevollmächtigten unterschrieben.

Positive
  • Timely disclosure of the tax-withholding transaction under Section 16
  • Transaction clearly described as RSU tax withholding (Code F), reducing ambiguity about insider intent
Negative
  • None.

Insights

TL;DR: Routine insider withholding for RSU taxes reported promptly; reflects compensation settlement, not a market sale.

The Form 4 documents a tax-withholding event tied to RSU vesting, reported under Code F. This is a common administrative disposition where the company retains shares to satisfy tax obligations rather than an open-market sale. The filing discloses post-transaction beneficial ownership of 207,599 Class A shares, which includes forthcoming RSU issuances. From a governance perspective, timely and clear disclosure maintains Section 16 compliance and reduces regulatory risk.

TL;DR: Small-scale disposition via withholding; insignificantly alters insider stake relative to reported holdings.

The reported withheld amount of 6,266 shares at $16.66 per share is presented as tax-related and therefore not a directional trade signal. The remaining beneficial ownership of 207,599 shares should be interpreted as the officer’s total exposure including unvested RSUs becoming issuable. There is no indication of market sales or other derivative activity in this filing.

Victoria Baltrus, indicata come Chief Accounting Officer dell'emittente, ha riportato una transazione in data 02/09/2025 relativa alle azioni ordinarie di Classe A di Oscar Health, Inc. (OSCR). Il documento indica una cessione con Codice F il 02/09/2025 in cui 6.266 azioni sono state trattenute dall'emittente per soddisfare il prelievo fiscale, a un prezzo riportato di $16,66 per azione. Dopo l'operazione, a Baltrus sono attribuite in via beneficiaria 207.599 azioni, che il modulo precisa includono azioni da emettere al vesting delle RSU. Il modulo è stato firmato da un procuratore il 04/09/2025.

Victoria Baltrus, identificada como la Chief Accounting Officer de la emisora, reportó una transacción el 02/09/2025 que involucra acciones ordinarias Clase A de Oscar Health, Inc. (OSCR). El formulario muestra una disposición con Código F el 02/09/2025 en la que se retuvieron 6.266 acciones por parte de la emisora para cubrir la retención de impuestos, a un precio informado de $16.66 por acción. Tras la operación, a Baltrus se le atribuyen beneficiariamente 207.599 acciones, que el informe indica que incluyen acciones que se emitirán al consolidarse las RSU. El formulario fue firmado por un apoderado el 04/09/2025.

빅토리아 발트러스(Victoria Baltrus)는 발행회사의 최고 회계 책임자(Chief Accounting Officer)로서 2025-09-02에 Oscar Health, Inc.(OSCR) 보통주(Class A)에 대한 거래를 보고했습니다. 제출서류에는 코드 F에 따른 처분이 2025-09-02에 이루어졌으며, 6,266주가 세금 원천징수를 충당하기 위해 발행회사에 의해 원천징수되었고, 보고된 주당 가격은 $16.66였습니다. 거래 후 발트러스는 207,599주를 실질적 소유로 보고되었으며, 서류에는 이 숫자에 RSU 베스팅 시 발행될 주식이 포함된다고 기재되어 있습니다. 해당 양식은 2025-09-04에 대리인(공증인)에 의해 서명되었습니다.

Victoria Baltrus, identifiée comme Chief Accounting Officer de l'émetteur, a déclaré une transaction en date du 02/09/2025 portant sur des actions ordinaires de Classe A d'Oscar Health, Inc. (OSCR). Le dépôt indique une cession Code F le 02/09/2025 où 6 266 actions ont été retenues par l'émetteur pour couvrir la retenue fiscale, au prix communiqué de 16,66 $ par action. Après la transaction, Baltrus détient bénéficiairement 207 599 actions, le formulaire précisant que cela comprend des actions devant être émises lors du vesting des RSU. Le formulaire a été signé par un mandataire le 04/09/2025.

Victoria Baltrus, angegeben als Chief Accounting Officer des Emittenten, meldete am 02.09.2025 eine Transaktion mit Class-A-Stammaktien von Oscar Health, Inc. (OSCR). Die Einreichung weist eine Verfügung mit Code F zum 02.09.2025 aus, bei der 6.266 Aktien vom Emittenten einbehalten wurden, um die Steuerabzüge zu erfüllen, zu einem angegebenen Preis von $16,66 je Aktie. Nach der Transaktion besitzt Baltrus wirtschaftlich 207.599 Aktien, wobei das Formular angibt, dass dies Aktien umfasst, die bei Vesting von RSUs ausgegeben werden. Das Formular wurde am 04.09.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Baltrus Victoria

(Last) (First) (Middle)
75 VARICK STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/02/2025 F 6,266(1) D $16.66 207,599(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Remarks:
/s/ Melissa Curtin, Attorney-in-fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Victoria Baltrus report on Form 4 for OSCR?

The report shows a Code F disposition on 09/02/2025 where 6,266 Class A shares were withheld to satisfy tax withholding related to RSU vesting.

How many OSCR shares does the reporting person beneficially own after the transaction?

The filing reports beneficial ownership of 207,599 Class A shares following the reported transaction, which the form states includes shares to be issued upon RSU vesting.

What price per share is reported for the withheld shares?

The withheld shares are reported at a price of $16.66 per share.

Does the Form 4 indicate an open-market sale by the insider?

No. The Form 4 indicates shares were withheld by the issuer to satisfy tax obligations (Code F), not sold in the open market.

Who signed the Form 4 and when was it signed?

The form is signed by Melissa Curtin, Attorney-in-fact on 09/04/2025.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Latest News

OSCR Latest SEC Filings

OSCR Stock Data

4.75B
212.61M
4.05%
76.86%
23.24%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK